Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Cytek Biosciences Inc
F:8EQ

Watchlist Manager
Cytek Biosciences Inc Logo
Cytek Biosciences Inc
F:8EQ
Watchlist
Price: 3.46 EUR
Market Cap: €454.2m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...

Wall St Price Targets

8EQ Price Targets Summary
Cytek Biosciences Inc

Wall Street analysts forecast 8EQ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 8EQ is 5.16 EUR with a low forecast of 4.35 EUR and a high forecast of 6.78 EUR.

8EQ Lowest Forecast
4.35 EUR
26% Upside
8EQ Average Forecast
5.16 EUR
49% Upside
8EQ Highest Forecast
6.78 EUR
96% Upside
Lowest Forecast
Price Target
4.35 EUR
26% Upside
Average Forecast
Price Target
5.16 EUR
49% Upside
Highest Forecast
Price Target
6.78 EUR
96% Upside
Cytek Biosciences Inc Competitors:
Price Targets
BARK
Bark Inc
348% Upside
BARK
Bark Inc
348% Upside

Revenue
Forecast

17% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
17% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 8%.

What are analyst estimates?

Gross Profit
Forecast

15% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
15% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Cytek Biosciences Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Cytek Biosciences Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss

What are analyst estimates?

See Also

Summary
8EQ intrinsic value, competitors valuation, and company profile.
DCF Valuation
8EQ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
8EQ stock valuation using valuation multiples.
Wall St Estimates
8EQ price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
8EQ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Cytek Biosciences Inc listings:
NASDAQ • USD
CTKB
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 8EQ's stock price target?
Price Target
5.16 EUR

According to Wall Street analysts, the average 1-year price target for 8EQ is 5.16 EUR with a low forecast of 4.35 EUR and a high forecast of 6.78 EUR.

What is the Revenue forecast for Cytek Biosciences Inc?
Projected CAGR
8%

Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 8%.

Back to Top
ALPHA SPREAD
Follow us
Join 342,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett